Search Results - "SCHLEIBNER, S"

Refine Results
  1. 1
  2. 2

    Three-year follow-up of malignancies in tacrolimus-treated renal recipients - an analysis of European multicentre studies by Cowlrick, I., Delventhal, H., Kaipainen, K., Krcmar, C., Petan, J., Schleibner, S.

    Published in Clinical transplantation (01-05-2008)
    “…:  Five prospective, multicentre adult renal studies of three yr duration conducted in Europe for which tacrolimus was used as the primary immunosuppressant in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis by Zanker, B, Schleibner, S, Schneeberger, H, Krauss, M, Land, W

    Published in Transplant international (1996)
    “…Pharmacokinetics of mycophenolic acid (MPA) was analyzed in eight patients with post-transplant acute renal failure. Furthermore, the effect of hemodialysis…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation by Landgraf, R, Nusser, J, Müller, W, Landgraf-Leurs, M M, Thurau, S, Ulbig, M, Kampik, A, Lachenmayr, B, Hillebrand, G, Schleibner, S

    Published in Diabetes (New York, N.Y.) (01-01-1989)
    “…The success rate of pancreas transplantation allows us to study in more detail the potential beneficial effects of normoglycemia on secondary complications in…”
    Get full text
    Journal Article
  10. 10

    The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation by Schneeberger, H, Schleibner, S, Illner, W D, Messmer, K, Land, W

    Published in Clinical transplants (1993)
    “…In a prospective, randomized, double-blind, placebo-controlled trial, rhSOD was given to cadaveric renal allograft recipients intravenously in a dose of 200 mg…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Positive donor and negative recipient cytomegalovirus status is a detrimental factor for long-term renal allograft survival by Petersen, P, Schneeberger, H, Schleibner, S, Illner, W D, Hofmann, G O, Land, W

    Published in Transplant international (1994)
    “…In 524 allogeneic cadaveric kidney transplants, the impact of cytomegalovirus (CMV) donor/recipient status on the incidence of CMV infection, CMV disease,…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Outcome of renal grafts after simultaneous kidney/pancreas transplantation by HILLEBRAND, G, ILLNER, W.-D, ABENDROTH, D, SCHNEEBERGER, H, PETRY, I, SCHLEIBNER, S, LANDGRAF, R, LAND, W

    Published in Diabetologia (01-08-1991)
    “…Nineteen patients with endstage renal failure due to Type 1 (insulin-dependent) diabetes mellitus received simultaneous pancreas/kidney transplants using…”
    Get full text
    Conference Proceeding Journal Article
  19. 19
  20. 20